The number of patients who require maintenance on anticoagulation therapy (warfarin/Coumadin ®) for minimizing risk of cardiovascular events like stroke or thromboembolism is increasing.

Maxim Group analyst Naz Rahman has reiterated their bullish stance on TLPH stock, giving a Buy rating on November 14. Naz Rahman has given his ...

The anticoagulation management system should provide an appropriate level of staff training, ongoing educational development, and documented competency assessment for all multidisciplinary ...

The improved engagement with HF patients intended to optimize GDMT was very modest, but did lead to increased use of MRAs.

Experts from NYU Langone Heart will present the latest advancements in cardiovascular science and clinical care at the 2024 American Heart Association's Scientific Sessions, held from November 16 to ...

PLC ("TC BioPharm" or the "Company") , a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that it has ...

This year's award marks 30 years since clinicians first used ECP to successfully treat chronic graft versus host <a target=_bla ...

There’s no “silver bullet” for this problem, which is largely driven by clinical inertia, but some efforts are chipping away ...

USA: A new study from the AUGUSTUS trial has provided new insights into the most effective antithrombotic strategies for ...

DOACs only and warfarin only are more likely to be prescribed to Medicare beneficiaries seeing clinicians in rural areas compared with urban areas.

Kawasaki disease (KD), an acute self-limited febrile illness that primarily affects children <5 years old, is the leading cause of acquired heart disease in developed countries, with the potential of ...

Introduction: Current guidelines recommend single anticoagulation (AC) therapy over combined AC plus anti-platelet (AP) therapy in patients with established cardiovascular disease (CVD) and ...